CA2320470A1 - Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media - Google Patents

Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media Download PDF

Info

Publication number
CA2320470A1
CA2320470A1 CA002320470A CA2320470A CA2320470A1 CA 2320470 A1 CA2320470 A1 CA 2320470A1 CA 002320470 A CA002320470 A CA 002320470A CA 2320470 A CA2320470 A CA 2320470A CA 2320470 A1 CA2320470 A1 CA 2320470A1
Authority
CA
Canada
Prior art keywords
protein
restricted
conjugate
polysaccharide
solid phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002320470A
Other languages
English (en)
French (fr)
Inventor
Andrew Lees
Douglas E. Shafer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2320470A1 publication Critical patent/CA2320470A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/291—Gel sorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/265—Adsorption chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/10—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
    • B01J20/103—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate comprising silica
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2220/00—Aspects relating to sorbent materials
    • B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
    • B01J2220/54—Sorbents specially adapted for analytical or investigative chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
CA002320470A 1998-02-05 1999-02-04 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media Abandoned CA2320470A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7379098P 1998-02-05 1998-02-05
US60/073,790 1998-02-05
PCT/US1999/002416 WO1999039739A1 (en) 1998-02-05 1999-02-04 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media

Publications (1)

Publication Number Publication Date
CA2320470A1 true CA2320470A1 (en) 1999-08-12

Family

ID=22115824

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002320470A Abandoned CA2320470A1 (en) 1998-02-05 1999-02-04 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media

Country Status (8)

Country Link
US (1) US6284250B1 (https=)
EP (1) EP1053021B1 (https=)
JP (1) JP2002502830A (https=)
AT (1) ATE421339T1 (https=)
AU (1) AU763349B2 (https=)
CA (1) CA2320470A1 (https=)
DE (1) DE69940338D1 (https=)
WO (1) WO1999039739A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248334B1 (en) * 1997-01-08 2001-06-19 Henry M. Jackson Foundation For The Advancement Of Military Medicine Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process
FR2806304B1 (fr) * 2000-03-17 2002-05-10 Aventis Pasteur Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie
WO2005072778A2 (en) * 2004-01-29 2005-08-11 Biosynexus, Inc. Use of amino-oxy functional groups in the preparation of vaccines conjugates
GB0409745D0 (en) * 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
GB0713880D0 (en) * 2007-07-17 2007-08-29 Novartis Ag Conjugate purification
US8207298B2 (en) * 2008-05-01 2012-06-26 Archemix Corp. Methods of separating biopolymer conjugated molecules from unconjugated molecules
WO2011017101A2 (en) 2009-07-27 2011-02-10 Fina Biosolutions, Llc Method for producing protein-carbohydrate vaccines reduced in free carbohydrate
MX2012006961A (es) 2009-12-17 2012-10-03 Fina Biosolutions Llc Reactivos quimicos para la activacion de polisacaridos en la preparacion de vacunas conjugadas.
DK2560738T3 (da) 2010-04-23 2019-08-26 Serum Inst India Ltd Simpel fremgangsmåde til samtidig fjernelse af flere urenheder fra dyrkningssupernatanter til ultralave niveauer
RU2015114330A (ru) 2012-09-17 2016-11-10 У.Р. Грейс Энд Ко.-Конн. Хроматографические среды и устройства
BR112015029051A2 (pt) 2013-05-20 2017-07-25 Shantha Biotechnics Private Ltd processos para a purificação de um conjugado de proteínas de polissacarídeos e para a fabricação de uma vacina
CN104324708B (zh) * 2014-11-05 2016-08-24 华玉叶 一种亲水色谱介质的制备方法
JP6882193B2 (ja) 2015-04-28 2021-06-02 バイオロジカル イー リミテッド 微生物莢膜多糖類からタンパク質および他の不純物を分離するための方法
CN114544841B (zh) * 2020-11-24 2024-09-03 武汉博沃生物科技有限公司 一种采用高效液相色谱法测定肺炎球菌多糖-蛋白结合疫苗中dmap残留量的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4923978A (en) * 1987-12-28 1990-05-08 E. I. Du Pont De Nemours & Company Process for purifying nucleic acids
US4929560A (en) 1988-02-03 1990-05-29 Damon Biotech, Inc. Recovery of tissue plasminogen activator
US5277813A (en) 1988-06-17 1994-01-11 S.A.C. Corporation Shielded stationary phases
US5106966A (en) 1989-07-10 1992-04-21 University Of Kansas Use of gel polymer for dna extraction with organic solvents
US5153312A (en) 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
US5278284A (en) 1992-05-14 1994-01-11 Miller Brewing Company Protein purification method
ES2160601T3 (es) * 1992-09-24 2001-11-16 Brigham & Womens Hospital Vacunas de conjugado de polisacaridos de estreptococos del grupo b tipo ii y tipo v-proteina.
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
NZ274376A (en) * 1993-09-22 1997-11-24 Jackson H M Found Military Med Activating soluble carbohydrate using cyanylating reagents for the production of immunogenic constructs
NZ304715A (en) * 1995-03-22 1999-07-29 Jackson H M Found Military Med Production of immunogenic constructs using organic cyanylating reagents to activate carbohydrates and then coupling the carbohydrate to a protein, peptide or hapten
TR199701547T1 (xx) * 1995-06-07 1998-03-21 Smithkline Beecham Biologicals S.A. Polisakarit antijen protein e�leni�i i�eren a��.
AUPN694895A0 (en) 1995-12-01 1996-01-04 Macquarie Research Limited Desalting and purification of oligosaccharides and their derivatives

Also Published As

Publication number Publication date
ATE421339T1 (de) 2009-02-15
AU763349B2 (en) 2003-07-17
US6284250B1 (en) 2001-09-04
WO1999039739A1 (en) 1999-08-12
EP1053021A1 (en) 2000-11-22
DE69940338D1 (de) 2009-03-12
AU2582999A (en) 1999-08-23
JP2002502830A (ja) 2002-01-29
EP1053021B1 (en) 2009-01-21

Similar Documents

Publication Publication Date Title
AU763349B2 (en) Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media
CA2358022C (en) Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
KR910002553B1 (ko) 폴리삭카라이드-단백질 결합체 및 이의 제조방법
CA2277141C (en) Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure
KR880001098B1 (ko) 헤모필루스 인플루엔재 b 다당류 엑소톡소이드 배합체 왁진의 제조방법
EP0971945B1 (en) Method for preparation of conjugate vaccines using uronium salt
US20020164644A1 (en) Adsorbents for high mobility group proteins and column for purifying body fluid
US4845042A (en) Adjuvant for immunization
WO2005090403A2 (en) Method and apparatus for antibody purification
WO2012061400A2 (en) Method for reduction of free polysaccharide in polysaccharide-protein vaccines reactions using ion-exchange matrices
WO1984001289A1 (en) Purified and antigenically selective vaccines for domestic animals
BE1025162B1 (fr) Pocede de purification pour les polysaccharides capsulaires
Shafer et al. Rapid and complete adsorption of unconjugated protein from protein-polysaccharide conjugate vaccines
ES2942133T3 (es) Purificación de polisacárido capsular estreptocócico
US3900461A (en) Lymphocyte stroma adsorbent
Malley et al. The isolation of reagin and blocking antibody by means of an immunoadsorbent
JP2721961B2 (ja) 血液製剤
RU2081170C1 (ru) Соединение на основе макропористого сополимера стирола и дивинилбензола в качестве иммуносорбента для удаления дифтерийного токсина из биологических жидкостей организма
Sakoda et al. A new isolation and purification method for staphylococcal protein A using membrane encapsulated rabbit IgG‐agarose
JPH0723319B2 (ja) 血液製剤から血液型抗体を除去する方法
AU2012227310B2 (en) Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
Whitesides et al. AF F IN ITY CH ROMATOG RAPHY
AU2004237870A1 (en) Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued